Conversation with The Cancer Letter NCI’s Rosenberg: Tumor infiltrating lymphocytes offer a strategy for treating recalcitrant solid cancers July 13, 2018Vol.44 No.28By Matthew Bin Han Ong
Immunologists seek ways to make TIL in solid tumors as effective as CAR T in blood cancers July 13, 2018Vol.44 No.28By Matthew Bin Han Ong
Drugs & Targets FDA limits the use of Tecentriq and Keytruda for some urothelial cancer patients July 06, 2018Vol.44 No.27
Drugs & Targets Novartis receives positive CHMP opinion for Kymriah for DLBCL, B-cell ALL July 06, 2018Vol.44 No.27
